Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03721705
What this trial is testing

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment+3 more
Renew Research, LLC 190
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Not applicableLooking for participantsNCT07803055
What this trial is testing

Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease

Who this might be right for
Subjective Cognitive Decline (SCD)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseAlzheimer's Disease Dementia+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 48
Not applicableLooking for participantsNCT07667478
What this trial is testing

NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE

Who this might be right for
Alzheimer s DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseMild Dementia
Chi-Ying (Roy) Lin 40
Large-scale testing (Phase 3)Looking for participantsNCT07170150
What this trial is testing

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT05399888
What this trial is testing

Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease Dementia
Biogen 416
Not applicableLooking for participantsNCT07089303
What this trial is testing

Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer's Disease
Chinese PLA General Hospital 750
Not applicableStudy completedNCT02414282
What this trial is testing

F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)

Who this might be right for
Alzheimer DiseaseProgressive Posterior Cortical Dysfunction (PPCD)
Tammie L. S. Benzinger, MD, PhD 20
Early research (Phase 1)Study completedNCT02094729
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Co., Ltd. 26
Not applicableLooking for participantsNCT06618807
What this trial is testing

Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI)

Who this might be right for
Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Unity Health Toronto 60
Early research (Phase 1)Ended earlyNCT03819699
What this trial is testing

Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD

Who this might be right for
Alzheimer Disease
H. Lundbeck A/S 3
Early research (Phase 1)Study completedNCT02221622
What this trial is testing

Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
University of Southern California 24
Not applicableLooking for participantsNCT06792877
What this trial is testing

Mindfulness for Cognition in Early-stage Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseTBI (Traumatic Brain Injury)+3 more
VA Boston Healthcare System 100
Not applicableLooking for participantsNCT07383311
What this trial is testing

Autophagy-Enhancers to Reduce Sleep Disturbances

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseSubjective Cognitive Decline (SCD)
University Medicine Greifswald 76
Not applicableUnknownNCT05050812
What this trial is testing

The Grounded Brain: How Sleeping Grounded Affects Memory and Perceptions

Who this might be right for
Mild Cognitive ImpairmentChronic Inflammation
California Institute of Integral Studies 8
Large-scale testing (Phase 3)Study completedNCT03486938
What this trial is testing

Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentProdromal Alzheimer's Disease
AgeneBio 164
Very early researchActive Not RecruitingNCT04075435
What this trial is testing

Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseAnxietyAgitation,Psychomotor+1 more
Mclean Hospital 12
Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Not applicableUnknownNCT03672279
What this trial is testing

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease

Who this might be right for
Dementia AlzheimersMild Cognitive ImpairmentCognition Disorders+1 more
University Hospital, Basel, Switzerland 100
Testing effectiveness (Phase 2)Ended earlyNCT02322021
What this trial is testing

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, Alzheimer Type
Eisai Inc. 70
Next Page